Candriam Equities L Biotechnology, V - Capitalisation/  LU0317020203  /

Fonds
NAV9/5/2024 Chg.-22.8501 Type of yield Investment Focus Investment company
2,242.9500USD -1.01% reinvestment Equity Candriam